Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12091661 Organic compositions to treat HSF1-related diseases

Patent 12091661 was granted and assigned to Arrowhead Pharmaceuticals, Inc. on September, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Arrowhead Pharmaceuticals, Inc.

0

Current Assignee

Arrowhead Pharmaceuticals, Inc.

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Ping Zhu0

Tracy S. Zimmermann0

Gregory Hinkle0

Wenlai Zhou0

Satyanarayana Kuchimanchi0

Stuart Milstein0

Markus Warmuth0

Date of Patent

September 17, 2024

0

Patent Application Number

177142720

Date Filed

April 6, 2022

0

Patent Citations

US Patent 7858592 Interfering RNAs against the promoter region of P53

0

US Patent 8090542 Functional and hyperfunctional siRNA

0

US Patent 8168606 RNAi inhibition of alpha-ENaC expression

0

US Patent 8293718 Organic compositions to treat HSF1-related diseases

0

US Patent 8481509 Organic compositions to treat HSF1-related diseases

0

US Patent 8623838 Organic compositions to treat HSF1-related diseases

0

US Patent 9096637 Organic compositions to treat HSF1-related diseases

0

US Patent 10287582 Organic compositions to treat HSF1-related diseases

0

...

Patent Primary Examiner

0

Patent abstract

The present disclosure relates to methods of treating heat shock factor 1 (HSF1)-related diseases such as cancer and viral diseases, using a therapeutically effective amount of a RNAi agent to HSF.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12091661 Organic compositions to treat HSF1-related diseases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool